| Schedule of Segment Information |
Selected
financial information for the Company’s operating segments is as follows:
| |
|
|
Year Ended December 31, |
|
| |
|
|
2018 |
|
|
|
2017 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
| Clinical
Laboratory Operations |
|
$ |
131,014 |
|
|
$ |
2,210,318 |
|
| Hospital
Operations |
|
|
14,417,676 |
|
|
|
877,898 |
|
| |
|
$ |
14,548,690 |
|
|
$ |
3,088,216 |
|
| Loss from operations |
|
|
|
|
|
|
|
|
| Clinical Laboratory
Operations |
|
$ |
(2,247,499 |
) |
|
$ |
(4,672,768 |
) |
| Hospital Operations |
|
|
(6,434,538 |
) |
|
|
(4,800,539 |
) |
| Corporate |
|
|
(4,542,583 |
) |
|
|
(6,602,800 |
) |
| |
|
$ |
(13,224,620 |
) |
|
$ |
(16,076,107 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
| Clinical Laboratory
Operations |
|
$ |
764,445 |
|
|
$ |
1,639,954 |
|
| Hospital Operations |
|
|
498,352 |
|
|
|
73,985 |
|
| Corporate |
|
|
1,047 |
|
|
|
1,382 |
|
| |
|
$ |
1,263,844 |
|
|
$ |
1,715,321 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
| Clinical Laboratory
Operations |
|
$ |
- |
|
|
$ |
- |
|
| Hospital
Operations |
|
|
213,105 |
|
|
|
1,422,002 |
|
| |
|
$ |
213,105 |
|
|
$ |
1,422,002 |
|
| |
|
Year
Ended December 31, |
|
| |
|
2018 |
|
|
2017 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Clinical
Laboratory Operations |
|
$ |
271,426 |
|
|
$ |
1,503,520 |
|
| Hospital Operations |
|
|
13,568,933 |
|
|
|
2,549,504 |
|
| Corporate |
|
|
2,707,416 |
|
|
|
3,436,773 |
|
| Assets of AMSG and
HTS classified as held for sale |
|
|
152,171 |
|
|
|
255,566 |
|
| Eliminations |
|
|
(2,500,646 |
) |
|
|
(1,454,570 |
) |
| |
|
$ |
14,199,300 |
|
|
$ |
6,290,794 |
|
|